Latest news for Rosetta Genomics (OTC:ROSGQ) Stock

Rosetta Genomics Ltd is an Israel based genomic diagnostics company operating globally. It is focused on research and development on diagnostics and therapeutics in the field of microRNAs. The firm markets and sells four diagnostic tests based on its microRNA technologies namely, RosettaGX Cancer Origin for the identification of the primary site of metastatic cancer, mi-LUNG, mi-KIDNEY which is a microRNA-based kidney tumor classification test for pathology samples and RosettaGx Reveal which is a microRNA-based assay for the diagnosis of indeterminate thyroid fine-needle aspirate samples. Its revenues include Clinical testing revenues and Licensing revenues, of which Clinical testing revenue is maximum. The group generates its revenues mainly from diagnosing patient tissue.

ROSETTA GENOMICS LTD by Rosetta Genomics, Ltd.

Rosetta Genomics Ltd

WIIM

NBTB

NBT Bancorp shares are trading higher after the company reported better-than-expected Q2 sales results and increased its quarterly dividend from $0.32 to $0.34 per share.

EFSC

Enterprise Financial Services shares are trading higher after the company reported better-than-expected Q2 financial results.

Wedbush analyst David Chiaverini maintains BOK Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOKF#NASDAQ">BOKF</a>) with a Neutral and raises the price target from $94 to $115.

News

Price Target

Analyst Ratings

BOKF

Wedbush Maintains Neutral on BOK Financial, Raises Price Target to $115

Ahead of second-quarter financial results, a Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) analyst says investors aren't focused on earnings, but rather what comes next <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/07/39892255/tesla-q2-earnings-preview-analyst-estimates-key-items-to-watch-can-major-turning-po">after Tuesday's report.</a>
The Tesla Analyst: Guggenheim analyst Ronald Jewsikow reiterated a Sell rating on Tesla and $134 price target.
The Analyst Takeaways: Investors will be focused on what comes next for Tesla and not the past earnings, Jewsikow said.
Read Also:&nbsp;<a href="https://www.benzinga.com/exclusives/24/07/39886192/exclusive-tesla-an-elon-musk-and-a-technology-story-first-ev-story-last-market-strategist-explains-w" target="_blank" rel="noreferrer noopener">EXCLUSIVE: Tesla ‘An Elon Musk And A Technology Story First, EV Story Last' — Market Strategist Explains Why To Buy The Stock</a>
The analyst said Tesla delaying the robotaxi event from Aug. 8 will be top of mind for investors.
"With the planned 8/8 event now formally delayed, investors will look for color on the new timeline, what to expect at the event and more details on the delay," Jewsikow said.
The delay in the Robotaxi event has led to investors seeing the segment as less actionable, according to the report.
The analyst said 2024 volume guidance could also be a key item to watch in the earnings report.
"We don't believe guiding for y/y volume growth is realistic, but we do not see CEO Elon Musk indicating negative volume growth as his forecast."
China and market share in the country could also be a key focus in the earnings report, the analyst said.
"How does TSLA return to growth with so much competitively priced product in China?"
The analyst expects Tesla to beat earnings per share estimates and miss on automotive gross margins (ex-credits) due to "large discounting actions."
Jewsikow currently ascribes no value to robotaxis, robots, artificial intelligence or insurance when forecasting a price target on Tesla.
TSLA Price Action: Tesla shares are down 1% to $249.25 on Tuesday versus a 52-week trading range of $138.80 to $278.98. Tesla stock is up 0.3% year-to-date in 2024, after gaining over 30% in the past month, as seen on the<a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent072324&amp;t=be2bearmibe3na1"> Benzinga Pro chart</a> below.
<figure class="wp-block-image size-full"><a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent072324&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="997" height="500" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/23103257/Screenshot-78.png" alt="" class="wp-image-451622" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/23103257/Screenshot-78.png 997w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/23103257/Screenshot-78-300x150.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/23103257/Screenshot-78-768x385.png 768w" sizes="(max-width: 997px) 100vw, 997px" /></a></figure>
Read Next:
<ul>
<li><a href="https://bzresearch.myclickfunnels.com/latest-research-webinar-redirect-evergreen?utm_source=website-content" target="_blank" rel="noreferrer noopener">Turn Trading Into The Ultimate Side Hustle Using Benzinga Tools In A Free Webinar</a></li>
</ul>

Analyst Color

Previews

Reiteration

TSLA

Tesla Analyst Asks 'Do Earnings Matter?' Ahead Of Q2 Report: Robotaxis, China, EV Guidance In Focus

Barrington Research analyst James Goss maintains Lions Gate Enter (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LGF#NYSE">LGF</a>) with a Outperform and maintains $12 price target.

Lions Gate Entertainment Corporation Class A Voting Shares

LGF/A

Barrington Research Maintains Outperform on Lions Gate Enter, Maintains $12 Price Target

Did you know that residential fires in the USA cost $10.8 billion in 2022 alone? A new hempcrete wall product, recently rated for one-hour fire resistance, could help reduce these staggering losses.
<h2>Americhanvre Cast Hemp Achieves Milestone</h2>
A wall product produced by Americhanvre Cast Hemp using easy spray<a href="https://www.benzinga.com/markets/cannabis/22/02/25762696/is-hempcrete-the-new-green-construction-material-it-could-soon-be-approved-as-just-that">&nbsp;hempcrete</a> has received a one-hour fire resistance rating from ASTM International. In a July 15 Facebook <a href="https://www.facebook.com/Americhanvre/posts/pfbid02pHmNFYmkWfGFJSVD6UqNU2oaW8nrJfJ8HSXtvEd9Bx3P465SKjffkSC7aYhUyoBjl">post</a>, the&nbsp;Pennsylvania-based company announced it is &quot;the first time a full-scale ASTM E119 test has been performed on a hempcrete wall section.&quot;
<h3>House Fires In The USA</h3>
In 2022, there were 374,300 residential building fires in the USA, resulting in 2,720 deaths, 10,250 injuries, and $10.8 billion in property losses. Over ten years (2013-2022), the USFA reported residential fires decreased by 4%, while deaths increased by 1%. Cooking was the leading cause of home fires in 2022, <a href="https://www.usfa.fema.gov/statistics/residential-fires/">accounting for</a> 47.5% of incidents.
<h2>Understanding The ASTM E119 Test</h2>
The <a href="https://www.astm.org/e0119-20.html">ASTM E119 test </a>evaluates how long building elements can contain a fire and retain structural integrity during a predetermined test exposure. Americhanvre noted that this successful test could unlock larger-scale commercial projects for the Ereasy system in the United States.
Also read:&nbsp;<a href="https://www.benzinga.com/markets/cannabis/24/06/39559684/how-south-dakota-became-the-uss-top-hemp-producer-in-just-three-years">How South Dakota Became The US&#39;s Top Hemp Producer In Just Three Years</a>
<h3>Test Details And Results</h3>
The product tested was a 12-inch-thick wall assembly using the Ereasy <a href="https://www.benzinga.com/topic/hempcrete">hempcrete system</a>, with lime plaster on both faces. The panel remained undamaged through a one-hour firing at 1700 degrees Fahrenheit and a subsequent hose stream test. It did not rise above ambient temperature, as calculated by Verdant Structural.
<h3>Future Implications For Hempcrete</h3>
In 2023, <a href="https://www.benzinga.com/general/biotech/24/02/37271000/u-s-army-invests-1-9m-to-develop-hemp-manufactured-buildings-for-military-operations">hempcrete</a> was approved as a non-structural wall infill system for the model U.S. residential building code by the International Code Council. The International Building Code might consider <a href="https://www.benzinga.com/topic/hemp">hempcrete</a> for commercial projects next year.
<h3>Significance Of The ASTM E119 Test</h3>
The ASTM E119 test measures the fire resistance of building materials by exposing them to controlled fire conditions. It assesses how long materials can contain a fire and maintain structural integrity. This test includes applying a standard fire hose stream to evaluate the material&#39;s resistance to both fire and water, crucial for predicting performance in real-world scenarios.
Also read:&nbsp;<a href="https://www.benzinga.com/markets/cannabis/24/07/39690898/no-more-getting-high-on-hemp-in-america-multiple-states-begin-intoxicating-hemp-crackdown">No More Getting High On Hemp In America? Multiple States Begin Intoxicating Hemp Crackdown</a>
These issues will be among the hot topics at the upcoming Benzinga Cannabis Capital Conference in Chicago this Oct. 8-9. Join us to get more insight into what the wave of weed legalization means for the future of investing in the&nbsp;industry. Hear directly from top executives, investors, advocates, and policymakers.&nbsp;<a href="https://www.eventbrite.com/e/benzinga-capital-conference-cannabis-fall-2024-tickets-858948065787?aff=oddtdtcreator" rel="noreferrer noopener" target="_blank">Get your tickets now</a>&nbsp;before prices go up by following&nbsp;<a href="https://www.eventbrite.com/e/benzinga-capital-conference-cannabis-fall-2024-tickets-858948065787?aff=oddtdtcreator" rel="noreferrer noopener" target="_blank">this link</a>.
Photo: AI-Generated Image.

Biotech

Cannabis

Emerging Markets

Entrepreneurship

Legal

Success Stories

Startups

Small Business

Markets

Tech

General

The Wall That Can Withstand 1700°F And Cut $10B In Losses: Fire-Resistant Hempcrete Now Certified

Wedbush analyst Alicia Reese maintains AMC Enter Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMC#NYSE">AMC</a>) with a Neutral and raises the price target from $3.5 to $4.

Wedbush Maintains Neutral on AMC Enter Hldgs, Raises Price Target to $4

CORRECTION: Former President Jimmy Carter Has Not Died

Owens & Minor shares are trading higher after the company reported preliminary Q2 financial results and issued FY24 guidance. The company entered into a definitive agreement to acquire Rotech Healthcare Holdings.

KREF

KKR Real Estate Finance Trust shares are trading higher after the company reported better-than-expected Q2 financial results.

Real estate analytics point to potential investment opportunities in Colorado, particularly in the popular Denver metro area. Nick Gerli, CEO of Reventure, a real estate analytics tool, highlighted on Wednesday that the price cut rate in Denver has reached 42% of all listings in June, the second-highest on record.
&#8220;Price cuts are getting ugly in certain housing markets,&#8221; Gerli said in a Wednesday tweet. &#8220;Nearly half of sellers are feeling pressure to reduce the price. A clear indication of a declining market.&#8221;
Don't Miss:
<ul>
<li>Rory McIlroy&#8217;s mansion in Florida is worth $22 million today, doubling from 2017 —<a href="https://benzinga.com/money/rory-mcilroys-florida-mansion-doubled-in-value"> here&#8217;s how to get started investing in real estate with just $100</a></li>
<li>Will the surge continue or decline on real estate prices?<a href="https://www.benzinga.com/money/realbricks"> People are finding out about risk-free real estate investing that lets you cash out whenever you want.</a></li>
</ul>
The trend isn&#8217;t isolated to Denver. Colorado Springs tops the list with a 45% price cut rate, Gerli said, indicating heavy downward pressure on home prices. Other markets seeing similar trends <a href="https://www.benzinga.com/real-estate/24/06/39529294/house-prices-in-pandemic-era-boom-towns-are-going-bust-as-prices-fall">include pandemic boomtowns</a> like Austin, Huntsville, Tampa, Dallas, and Jacksonville.
However, the Colorado Association of Realtors paints a more nuanced picture. While inventory has indeed increased – up 24.3% for single-family homes in the Denver metro area compared to a year ago – median prices are still daunting for many, which has triggered price reductions in the state's major metro areas. The median price for single-family homes in the Denver metro area is $637,000, up just over 1% year-over-year. Interestingly, Gerli&#8217;s data reveals variation within metro areas. In Denver, some ZIP codes surrounding the urban core see up to 55% of sellers cutting prices, while others on the east side show only 25% doing so.
&#8220;The tables are starting to turn for buyers and sellers in Boulder and Broomfield counties," Kelly Moye, a Boulder-area realtor, noted in a report. "New listings continue to hit the market, and buyers remain watchful and waiting.&#8221;
<hr class="wp-block-separator has-alpha-channel-opacity" />
Trending: Commercial real estate has historically outperformed the stock market, and<a href="https://www.benzinga.com/money/marcus-millichap-backed-platform-makes-it-easy-to-invest-in-real-estate"> this platform allows individuals to invest in commercial real estate with as little as $5,000 offering a 12% target yield with a bonus 1% return boost today!</a>
<hr class="wp-block-separator has-alpha-channel-opacity" />
The discrepancy between high inventory and sustained prices indicates a market dynamic waiting for flux. Patrick Muldoon, a Colorado Springs-area realtor, warns of broader economic factors. &#8220;Are we entering a corrective phase? It appears many indicators are pointing in that direction,&#8221; he said, citing manufacturing contraction and concerns in the commercial real estate market.
The current market conditions present a dichotomy: while <a href="https://www.benzinga.com/real-estate/24/07/39646579/buyers-market-is-emerging-as-homes-sell-below-list-price-for-first-time-since-pandemic">price cuts suggest a buyer&#8217;s market</a>, sustained high prices indicate ongoing seller strength. The tension creates potential opportunities for savvy investors who can navigate the localized nature of the trends.
However, challenges remain. The CAR Housing Affordability Index remains near all-time lows, down 4.4% in the metro area compared to last year, the Colorado Association of Realtors said. High interest rates, rising insurance costs, and property tax hikes impact buyer behavior.
Read Next:
<ul>
<li>This Jeff Bezos-backed startup will allow you to<a href="https://www.benzinga.com/money/bezos-landlord-100-dollars"> become a landlord in just 10 minutes, and you only need $100</a>.</li>
<li>Sun Belt's booming real estate market prepares for millions of new inhabitants —<a href="https://www.benzinga.com/money/integris"> Here&#8217;s how to find the region's best deals!</a></li>
</ul>

Real Estate

Colorado's Housing Market May Be Investable As 'Price Cut Rate Just Hit 42%,' Suggests Market Executive

Service Includes Comprehensive Generative AI Model Features And NVIDIA NeMo Retriever Microservices For Accurate Responses; Accenture, Aramco, AT&amp;T, Uber Among First To Access New Service

NVDA

UBER

NVIDIA Announces AI Foundry Service To Enable Enterprises And Nations To Build Custom 'Supermodels' Using Llama 3.1 405B And NVIDIA Nemotron Models

Vale (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VALE#NYSE">VALE</a>) is set to open a new open-pit mine at the historic Stobie mine site in Sudbury, Ontario. The original underground mine operated from 1914 to 2017, producing over 375 million tons of nickel and <a href="https://www.benzinga.com/topic/copper">copper ore</a>.
Vale's Toronto-based base metal arm expects that the open pit project will cost $149 million over the next four years. The initial production target is 300,000 tons of nickel and copper this year, ramping up to 1.5 million tons by 2025. Additionally, the mine will yield valuable byproducts, including cobalt and precious metals.
Now read: <a href="https://www.benzinga.com/markets/commodities/24/07/39894211/liberty-gold-ceo-remains-bullish-but-political-developments-will-influence-markets-direction">Liberty Gold CEO Remains Bullish, But &#8216;Political Developments Will Influence Market&#8217;s Direction&#8217;</a>
&#8220;This is a $149 million project that marks a new era of cooperation and partnership," said Vale Base Metals' Director of Ontario Operations, Gord Gilpin <a href="https://www.thesudburystar.com/news/local-news/vale-engages-partners-for-open-pit-mine-at-stobie">per</a> The Sudbury Star. He praised the involvement of local contractors, including indigenous businesses and the United Steelworkers Union (USW).
"This project is not just about mining. It is about creating sustainable and inclusive growth," he added.
Mining contractor Thiess will oversee the Stobie alongside USW&#8217;s Local 6500 outlet, which has more than 2600 members in the Sudbury area alone.
&#8220;We will have approximately 62 to 80 new members during the lifetime of this project,&#8221; said Nick Larochelle, president of USW Local 6500. Larochelle highlighted that the jobs created include excavator operators, dozer operators, haulage truck drivers, and maintenance workers.
The project will fall under the oversight of Shaun Usmar, a veteran mining executive who has been appointed as Vale's <a href="https://vale.com/w/vale-base-metals-appoints-shaun-usmar-as-new-chief-executive-officer-1/-/categories/1968806">new base metals boss</a>. Usmar brings over 30 years of industry experience, most recently serving as founder and CEO of Triple Flag Precious Metals. His extensive background includes key roles at Barrick Gold Corp., Xstrata Plc, and BHP Billiton, and now he'll oversee Vale's Canadian, Brazilian and Indonesian base metal operations.
Last year, the company separated nickel and copper operations from its iron ore business, looking to streamline its operations.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/government/24/07/39894362/exclusive-impossible-metals-ceo-says-presale-agreements-quite-attractive-for-funding-deep-sea-projec">EXCLUSIVE: Impossible Metals CEO Says Presale Agreements &#8216;Quite Attractive&#8217; For Funding Deep-Sea Projects Vs. IPO</a></li>
</ul>
Benzinga Mining is the bridge between mining companies and retail investors. Reach out to <a href="mailto:licensing@benzinga.com" target="_blank" rel="noreferrer noopener">licensing@benzinga.com</a> to get started!
Photo: Shutterstock

Large Cap

Commodities

VALE

Vale Invests $149M In Canadian Nickel-Copper Mine, Projects 1.5 Million Tons Output By 2025

Snowflake's AI Research Team, in collaboration with the open source community, launches a Massive LLM Inference and Fine-Tuning System Stack — establishing a new state-of-the-art solution for open source inference and fine-tuning systems for multi-hundred billion parameter models like Llama 3.1 405B

Contracts

SNOW

Snowflake, Meta Partner To Optimize New Flagship Model Family In Snowflake Cortex AI

Moody&#8217;s Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCO#NYSE">MCO</a>) shares are trading lower after reporting <a target="_blank" href="https://www.benzinga.com/pressreleases/24/07/b39902219/moodys-corporation-reports-results-for-second-quarter-2024" rel="noreferrer noopener">second-quarter results.</a>
The company reported <a target="_blank" href="https://s203.q4cdn.com/694693571/files/doc_financials/2024/q2/2Q24-Earnings-Release-vFINAL.pdf" rel="noreferrer noopener">quarterly </a>adjusted earnings per share of $3.28, beating the street view of $3.02. Quarterly sales of $1.817 billion,<a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener"> beating the street view of $1.725 billion.</a>
&#8220;The 22% growth in revenue is driving a 21% increase in operating cash flow, enabling us to raise share repurchase guidance to $1.3 billion,&#8221; said Chief Financial Officer Noémie Heuland.
Moody&#8217;s Analytics revenue grew 7% from the prior-year period reflecting strong demand for Moody&#8217;s proprietary data and unique analytical insights. Moody&#8217;s Investors Service (MIS) achieved 36% revenue growth from the prior-year period.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/equities/24/07/39907251/tesla-extends-0-interest-loan-offer-in-china-amid-sales-pressure-details" rel="noreferrer noopener">Tesla Extends 0% Interest Loan Offer In China Amid Sales Pressure: Details</a>
The company&#8217;s adjusted operating margin was 49.6%, up 590 basis points from the prior-year period.
On July 22, 2024, the Board of Directors declared a regular quarterly dividend of $0.85 per share of MCO Common Stock.
The dividend will be payable on September 6 to stockholders of record at the close of business on August 16.
Outlook: Moody&#8217;s Corp raised its FY24 adjusted EPS outlook to $11.00-$11.40 (prior $10.40-$11.00) versus the $11.02 estimate.
The company projects revenues to increase in the low-teens percent range (prior: high-single-digit to low-double-digit percent range) versus $6.63 billion estimate.
Price Action: MCO shares are trading higher by 0.65% to $453.27 at last check Tuesday.
Photo via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39901629/elon-musk-says-google-co-founder-and-one-of-his-best-friends-larry-page-thought-eventually-we-will-a" target="_blank" rel="noreferrer noopener">Elon Musk Says Google Co-Founder And One Of His &#8216;Best Friends&#8217; Larry Page Thought Eventually We Will All &#8216;Upload Our Minds To The Computer&#8217;</a></li>
</ul>

Earnings

Equities

Guidance

Buybacks

Moody's Raises Share Repurchase Guidance To $1.3B After Q2 Earnings - Details

Financial giants have made a conspicuous bearish move on Tenet Healthcare. Our analysis of options history for Tenet Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>) revealed 9 unusual trades.
Delving into the details, we found 22% of traders were bullish, while 44% showed bearish tendencies. Out of all the trades we spotted, 4 were puts, with a value of $461,910, and 5 were calls, valued at $359,416.
<h3>Expected Price Movements</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $125.0 and $150.0 for Tenet Healthcare, spanning the last three months.
<h3>Volume &amp; Open Interest Development</h3>
In terms of liquidity and interest, the mean open interest for Tenet Healthcare options trades today is 810.25 with a total volume of 4,215.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Tenet Healthcare's big money trades within a strike price range of $125.0 to $150.0 over the last 30 days.
<h3>Tenet Healthcare Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1721747811_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>THC</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/15/24</td>
<td>$6.8</td>
<td>$6.0</td>
<td>$6.0</td>
<td>$125.00</td>
<td>$238.8K</td>
<td>1.4K</td>
<td style="text-align: right;">352</td>
</tr>
<tr>
<td>THC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>08/16/24</td>
<td>$6.0</td>
<td>$6.0</td>
<td>$6.0</td>
<td>$140.00</td>
<td>$178.5K</td>
<td>883</td>
<td style="text-align: right;">303</td>
</tr>
<tr>
<td>THC</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>11/15/24</td>
<td>$7.1</td>
<td>$5.8</td>
<td>$6.0</td>
<td>$125.00</td>
<td>$107.4K</td>
<td>1.4K</td>
<td style="text-align: right;">236</td>
</tr>
<tr>
<td>THC</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/15/24</td>
<td>$6.0</td>
<td>$5.9</td>
<td>$6.0</td>
<td>$125.00</td>
<td>$69.6K</td>
<td>1.4K</td>
<td style="text-align: right;">352</td>
</tr>
<tr>
<td>THC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/16/24</td>
<td>$6.0</td>
<td>$5.3</td>
<td>$6.0</td>
<td>$140.00</td>
<td>$60.0K</td>
<td>883</td>
<td style="text-align: right;">403</td>
</tr>
</tbody>
</table>

<h3>About Tenet Healthcare</h3>
Tenet Healthcare is a Dallas-based healthcare services organization. It operates a collection of hospitals (about 60 as of December 2023) and over 450 ambulatory surgery centers and other outpatient facilities across the U.S., primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.
<h3>Tenet Healthcare's Current Market Status</h3>
<ul>
<li>With a trading volume of 492,958, the price of THC is up by 2.27%, reaching $137.96.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 1 days from now.</li>
</ul>
<h3>What The Experts Say On Tenet Healthcare</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $129.4.
<ul>
<li>An analyst from Cantor Fitzgerald downgraded its action to Overweight with a price target of $112. </li>
<li>Maintaining their stance, an analyst from Barclays continues to hold a Overweight rating for Tenet Healthcare, targeting a price of $156. </li>
<li>In a cautious move, an analyst from Cantor Fitzgerald downgraded its rating to Overweight, setting a price target of $112. </li>
<li>An analyst from Cantor Fitzgerald downgraded its action to Overweight with a price target of $112. </li>
<li>An analyst from Deutsche Bank has decided to maintain their Buy rating on Tenet Healthcare, which currently sits at a price target of $155. </li>
</ul>
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Tenet Healthcare with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Options

This Is What Whales Are Betting On Tenet Healthcare

Investors with a lot of money to spend have taken a bearish stance on IBM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBM#NYSE">IBM</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with IBM, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 12 uncommon options trades for IBM.
This isn't normal.
The overall sentiment of these big-money traders is split between 41% bullish and 50%, bearish.
Out of all of the special options we uncovered, 7 are puts, for a total amount of $302,477, and 5 are calls, for a total amount of $282,390.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $177.5 to $190.0 for IBM over the last 3 months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in IBM's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to IBM's substantial trades, within a strike price spectrum from $177.5 to $190.0 over the preceding 30 days.
<h3>IBM Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1721747806_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>IBM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$19.4</td>
<td>$19.3</td>
<td>$19.4</td>
<td>$180.00</td>
<td>$139.6K</td>
<td>305</td>
<td style="text-align: right;">148</td>
</tr>
<tr>
<td>IBM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$15.05</td>
<td>$14.4</td>
<td>$14.6</td>
<td>$190.00</td>
<td>$97.8K</td>
<td>1.0K</td>
<td style="text-align: right;">67</td>
</tr>
<tr>
<td>IBM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$15.75</td>
<td>$14.4</td>
<td>$14.75</td>
<td>$190.00</td>
<td>$61.9K</td>
<td>565</td>
<td style="text-align: right;">67</td>
</tr>
<tr>
<td>IBM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>07/26/24</td>
<td>$2.64</td>
<td>$2.62</td>
<td>$2.62</td>
<td>$177.50</td>
<td>$43.7K</td>
<td>1.0K</td>
<td style="text-align: right;">368</td>
</tr>
<tr>
<td>IBM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/26/24</td>
<td>$2.74</td>
<td>$2.58</td>
<td>$2.64</td>
<td>$177.50</td>
<td>$40.3K</td>
<td>1.0K</td>
<td style="text-align: right;">965</td>
</tr>
</tbody>
</table>

<h3>About IBM</h3>
IBM looks to be a part of every aspect of an enterprise's IT needs. The company primarily sells software, IT services, consulting, and hardware. IBM operates in 175 countries and employs approximately 350,000 people. The company has a robust roster of 80,000 business partners to service 5,200 clients-which includes 95% of all Fortune 500. While IBM is a B2B company, IBM's outward impact is substantial. For example, IBM manages 90% of all credit card transactions globally and is responsible for 50% of all wireless connections in the world.
After a thorough review of the options trading surrounding IBM, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Present Market Standing of IBM</h3>
<ul>
<li>With a volume of 505,291, the price of IBM is down -0.36% at $183.5. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 1 days.</li>
</ul>
<h3>Professional Analyst Ratings for IBM</h3>
1 market experts have recently issued ratings for this stock, with a consensus target price of $200.0.
<ul>
<li>In a cautious move, an analyst from Goldman Sachs downgraded its rating to Buy, setting a price target of $200. </li>
</ul>
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for IBM with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

This Is What Whales Are Betting On IBM

Financial giants have made a conspicuous bearish move on Thermo Fisher Scientific. Our analysis of options history for Thermo Fisher Scientific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TMO#NYSE">TMO</a>) revealed 10 unusual trades.
Delving into the details, we found 20% of traders were bullish, while 40% showed bearish tendencies. Out of all the trades we spotted, 4 were puts, with a value of $162,140, and 6 were calls, valued at $422,002.
<h3>Predicted Price Range</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $500.0 to $660.0 for Thermo Fisher Scientific over the recent three months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Thermo Fisher Scientific's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Thermo Fisher Scientific's significant trades, within a strike price range of $500.0 to $660.0, over the past month.
<h3>Thermo Fisher Scientific Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1721747801_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TMO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$10.6</td>
<td>$10.4</td>
<td>$10.4</td>
<td>$640.00</td>
<td>$104.0K</td>
<td style="text-align: right;">470</td>
<td style="text-align: right;">191</td>
</tr>
<tr>
<td>TMO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$10.5</td>
<td>$10.4</td>
<td>$10.4</td>
<td>$640.00</td>
<td>$104.0K</td>
<td style="text-align: right;">470</td>
<td style="text-align: right;">2</td>
</tr>
<tr>
<td>TMO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/20/24</td>
<td>$16.6</td>
<td>$11.9</td>
<td>$15.9</td>
<td>$590.00</td>
<td>$89.0K</td>
<td style="text-align: right;">251</td>
<td style="text-align: right;">56</td>
</tr>
<tr>
<td>TMO</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$32.0</td>
<td>$23.1</td>
<td>$26.8</td>
<td>$500.00</td>
<td>$80.4K</td>
<td style="text-align: right;">17</td>
<td style="text-align: right;">30</td>
</tr>
<tr>
<td>TMO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$7.2</td>
<td>$6.4</td>
<td>$7.2</td>
<td>$660.00</td>
<td>$61.9K</td>
<td style="text-align: right;">239</td>
<td style="text-align: right;">86</td>
</tr>
</tbody>
</table>

<h3>About Thermo Fisher Scientific</h3>
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of end-2023 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (10%); life science solutions (23%); and lab products and services, which includes CRO services (54%).
<h3>Where Is Thermo Fisher Scientific Standing Right Now?</h3>
<ul>
<li>With a trading volume of 671,684, the price of TMO is up by 1.86%, reaching $556.56.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 1 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for Thermo Fisher Scientific</h3>
A total of 2 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $600.0.
<ul>
<li>Maintaining their stance, an analyst from Barclays continues to hold a Equal-Weight rating for Thermo Fisher Scientific, targeting a price of $600. </li>
<li>An analyst from Evercore ISI Group has decided to maintain their Outperform rating on Thermo Fisher Scientific, which currently sits at a price target of $600. </li>
</ul>
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Thermo Fisher Scientific with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Decoding Thermo Fisher Scientific's Options Activity: What's the Big Picture?

Vertical Research analyst Kevin McCarthy initiates coverage on Belden (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BDC#NYSE">BDC</a>) with a Buy rating and announces Price Target of $110.

Initiation

Vertical Research Initiates Coverage On Belden with Buy Rating, Announces Price Target of $110

Guggenheim analyst Yatin Suneja initiates coverage on Alumis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALMS#NASDAQ">ALMS</a>) with a Buy rating and announces Price Target of $32.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

Rosetta Genomics

News

Latest news for Rosetta Genomics (OTC:ROSGQ) Stock